CLEMSON, SC--The Clemson University Genomics Institute here has signed a two-year contract with the Swiss life sciences company Novartis to establish the framework for sequencing the rice genome quickly and efficiently, the institute's director, Rod Wing, told BioInform. Novartis is expected to announce the agreement this week, he said.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.